Skip to content

To study the effect and safety of an Anti-acne cream

Evaluation of the efficacy and in use tolerance of a Product, CLEARICA®ANTI-ACNE CREAM, in men and women.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045553
Enrollment
30
Registered
2022-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: CLEARICA®ANTI-ACNE CREAM: Face will be rinsed with water. Approximately 0.5 g of anti-acne cream.(visually, this is the size of a green pea)will be applied to each side of the face. P

Sponsors

PhytoMyco Research Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Voluntary men and women between 16 and 30 years of age (approximately equal number). 2. Having mild to moderate active acne or Non-cystic acne. 3. Not on any treatment for acne. 4. Accepting not to use products with the same end benefit during the entire study duration. 5. Cooperating, informed of the need and duration of the examinations, and ready to comply with protocol procedures. 6. Having signed a Consent Form and will be once informed orally and in writing of all information concerning the study procedures and study objectives.

Exclusion criteria

Exclusion criteria: 1.Pregnancy by history and lactating women. 2. Premenstrual women and women on oral contraceptives. 3. Skin allergy antecedents or atopic subject. 4. Hypersensitivity to any cosmetic product, raw material. 5. PCOD, hirsutism, any hormonal issues etc by history or clinical examination. 6. For whom the Investigator considers that he/she will not be compliant with study procedures. 7. Any clinically significant systemic or cutaneous disease, which may interfere with study treatments or procedures. 8. Participants on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month). 9. Participant in an exclusion period or already participating in another similar cosmetic or therapeutic trial as identified during screening on visit 1 (V1).

Design outcomes

Primary

MeasureTime frame
Evaluation of Acne lesions and redness by Clinical evaluation, Instrumentation and Self evaluation.Timepoint: Day 0, 72 hours, Day 7, Day 21

Secondary

MeasureTime frame
Evaluation of tolerance of the test productTimepoint: Day 0, 72 hours, Day 7, Day 21

Countries

India

Contacts

Public ContactMr Chidambara N

PhytoMyco Research Pvt. Ltd.

chidambara@phytomyco.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026